Creative Components
Permanent URI for this collection
Browse
Search Collection
1 - 5 of 1711
-
PublicationNavigate Up : Fostering Triumphs in Women's Professional Empowerment( 2024-05)The Navigate Up App serves as a strategic solution to address the gender pay gap and empower women in their professional journeys. By offering tailored guidance in negotiating fair salaries, providing access to personalized learning resources, and fostering a supportive community, the app aims to equip women with the tools needed to navigate systemic challenges, uplevel their careers, and contribute to diminishing gender disparities in the workforce.
-
PublicationAquatic Vaccines: How They Are Developed and Why They Are Necessary( 2024-05)Aquatic vaccines are commonly used in aquaculture to protect aquatic livestock against bacteria, parasites, and viruses that may cause disease. There are several types of aquatic vaccines, including inactivated vaccines, live-attenuated vaccines, subunit vaccines, and recombinant live vector vaccines. There are a few ways these vaccines can be administered, including injection administration, immersion administration, and oral administration. Currently, aquatic vaccines are necessary to protect aquatic livestock from disease and decrease the use of antibiotics.
-
PublicationBlockchain Disruption: Transforming Traditional Finance through Distributed Ledger Technology( 2024-05)Blockchain technology has emerged as a disruptive force in the financial industry, fundamentally changing the nature of financial transactions, record-keeping, and verification processes. The article thoroughly examines blockchain's implications for financial services, including its fundamental principles, real applications, associated advantages, present issues, and potential improvements. Blockchain technology is basically built on distributed ledger technology (DLT), cryptographic hashing, consensus processes, and programmable smart contracts. Using these characteristics, blockchain enables secure, peer-to-peer transactions that do not require middlemen, resulting in improved levels of security, transparency, and operational efficiency in financial ecosystems. Exploring the practical applications of blockchain technology in finance reveals its potential in a wide range of disciplines, including payment systems, remittances, trade finance, capital markets, and the developing realm of digital assets. Blockchain-based payment networks, for example, provide rapid cross-border transactions at a cheaper cost than traditional payment infrastructures. Similarly, blockchain has the potential to improve trade finance processes, lower fraud risks, and increase supply chain financing transparency. Furthermore, blockchain's ability that mitigate settlement cycles, increase transaction transparency, and allow for fractional asset ownership through tokenization procedures demonstrates its potential to change financial markets. The emergence of digital assets and cryptocurrencies as new investment options highlights blockchain's disruptive impact on financial markets and regulatory standards. Nonetheless, blockchain adoption in banking faces several challenges, including scalability constraints, legal uncertainty, interoperability issues, and privacy concerns. To encourage wider use, measures addressing these challenges must be established, such as scalable solutions, regulatory frameworks, and interoperability standards. Looking ahead, blockchain technology in finance will be impacted by emerging topics such as decentralized finance (DeFi), central bank digital currencies (CBDCs), and blockchain interoperability protocols. These advancements are projected to cause substantial changes in financial ecosystems, emphasizing blockchain's continued relevance and revolutionary potential. In a nutshell, this study demonstrates blockchain technology's disruptive potential for financial services, ushering in a paradigm shift characterized by enhanced efficiency, transparency, and accessibility. It presents a detailed assessment of blockchain's applications, benefits, issues, and future prospects in finance.
-
PublicationAndrostenone Effects on Horses( 2024-05-06)How can androstenone, a pheromone from boars, influence the behavior of horses? Horses communicate through olfactory chemical signals, generally called pheromones. Pheromones that can elicit variable effects on other species are called interomones. Androstenone is a sex pheromone secreted in boar saliva that binds to OR7D4 receptors of the vomeronasal organ and nasal epithelium of horses (Choi and Yoon, 2022). Pheromones are chemical substances produced by an animal that serves as a stimulus to other individuals of that species to elicit one or more behavioral responses (Choi and Yoon, 2022).
-
PublicationThe Treatment of Refractory Ventricular Fibrillation: What Works, What Doesn’t, and What’s Next( 2024-05)Background: Cardiac arrest is a sudden heart condition that can cause ventricular fibrillation (VF). The current standard for the treatment of VF is defibrillation. After multiple defibrillations without a change in rhythm, the VF is refractory and called refractory ventricular fibrillation (RVF). This study reviews novel treatments for RVF and compares them to traditional Advanced Cardiac Life Support (ACLS) treatments. Objectives: This review aims to summarize novel treatments for RVF and identify which treatments would benefit neurological and hospital discharge outcomes. Methods: Literature pertaining to RVF and treatments that included double sequential defibrillation (DSD), esmolol, and extracorporeal cardiopulmonary resuscitation (eCPR) were reviewed. Different clinical study designs were utilized, such as observational case studies and randomized controlled trials. Findings: Multiple studies on DSD and esmolol provided different information, but some indicated that outcomes proved superior to traditional methods. eCPR studies indicated that RVF treatments with eCPR had vastly superior outcomes to conventional methods. Conclusions: DSD and esmolol studies had conflicting findings, and more studies need to be done in a randomized controlled trial to prove the efficacy of DSD and esmolol. However, the usage of DSD and esmolol should be considered in patients with RVF if the standard of care is not working and if resources do not allow for eCPR to be performed. eCPR’s randomized controlled trials proved superior in RVF outcomes and should be utilized as a standard in cardiac arrest algorithms if resources are available.